What healing actually looks like

Anonymized clinical accounts and evidence-based narrative reporting on what psilocybin-assisted therapy looks like in practice — for people with PTSD, depression, end-of-life anxiety, and addiction.

Clinical Accounts

Documented outcomes from real sessions

Case 01

"I hadn't slept without nightmares in 11 years." A veteran's account of two psilocybin sessions.

A Marine Corps veteran with combat PTSD describes the experience, the preparation, the integration — and what changed. All identifying details altered with subject consent.

Veterans & PTSD·16 min read

Case 02

Treatment-Resistant Depression: When Nothing Else Had Worked for Seven Years

A clinical account of a patient who had failed four antidepressants, two rounds of TMS, and two years of CBT before a single psilocybin session produced a sustained response.

Depression·12 min read

Case 03

End-of-Life Anxiety: What Psilocybin Gave a Terminal Cancer Patient

The Johns Hopkins end-of-life trials produced some of the most striking data in the field. This is what that data looks like as a human experience.

End-of-Life Care·10 min read

How we report case studies

Myco Brief's case study coverage is based on direct interviews with subjects, clinicians, or facilitators, cross-referenced against published literature where possible. All identifying details are altered or omitted with explicit subject consent.

We do not publish case studies that sensationalize the experience or that could reasonably be interpreted as promotional. Our editorial standard is the same as it would be for any medical or psychiatric reporting: accuracy, dignity, and honest representation of complexity.

If you have a story you'd like to share — as a client, facilitator, or clinician — you can reach our editorial team through the contact page.

Indications Covered

PTSD & Trauma

Combat trauma, sexual assault, childhood abuse, first responder trauma — the largest segment of our case study coverage.

Treatment-Resistant Depression

Cases where conventional antidepressants and psychotherapy have failed to produce sustained improvement.

End-of-Life Anxiety

Terminal illness, existential distress, and the role of psilocybin in facilitating acceptance. Based on Johns Hopkins and NYU protocols.

Addiction

Alcohol, tobacco, and opioid dependence. A growing area of evidence with several well-designed trials completed.